AzTrials
AzTrials

Nociceptive PainALGOBLOC-1NCT04925336

Cerebral and Autonomic Responses to Pain in Healthy Humans

A study testing Nociceptive stimulation in people with Nociceptive Pain and Anesthesia, run by Hospices Civils de Lyon at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Evaluating the intraoperative pain is a major challenge for the anesthesia team. During anesthesia, changes in heart rate and blood pressure are interpreted qualitatively to evaluate the sympathetic response to nociceptive stimulation or the adaptation of analgesia during surgery. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Nociceptive Pain, Anesthesia, Healthy
What is being tested?
Nociceptive stimulation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
21 participants
Where
1 siteFrance
Study dates
6 Apr 2021to 8 Jul 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Healthy volunteer over 18 years old
  • signed informed consent
  • affiliated to a social security

Who cannot join

  • Chronic pathology requiring chronic treatment
  • Cardiac rhythm disorders, pacemaker, cardiotropic treatment
  • Taking opioid analgesics during the previous week
  • Painful chronic, or migraine
  • Pathology of the hand, acrosyndrome, carpal tunnel syndrome
  • Pregnancy
  • People placed under protection of justice

Trial locations and contacts

1 site in 1 country.

France1 site
  • Service de Neurologie Fonctionnelle et Epileptologie Hôpital Neurologique, GHE Hospices civils de Lyon

    Bron, 69677

Other trials in France

About this study

Official title: Study of Cortical Cerebral Response and Neurovegetative Response to a Nociceptive Stimulus Among Healthy Volunteers

Evaluating the intraoperative pain is a major challenge for the anesthesia team. During anesthesia, changes in heart rate and blood pressure are interpreted qualitatively to evaluate the sympathetic response to nociceptive stimulation or the adaptation of analgesia during surgery. The new nociception monitors under development quantitatively explore other variables dependent on sympathetic activity or sympathetic / parasympathetic balance, such as the pulse wave amplitude measurement (Surgical Pleth Index (SPI index)), the pupil dilation reflex, respiratory sinus arrhythmia (ANI, Analgesia Nociception Index), or skin conductance index. Taken independently, these tools provide an assessment of nociception based on variations in the autonomic system, more robust than simply observing heart rate or blood pressure raw values.

However, the relationship between variations in the neurovegetative system and pain can be compromised by various factors or intraoperative events such as hypovolemia, bleeding, certain sympathomimetic or sympatholytic treatments, the hypnosis depth, ventilation variation, fast filling, or body temperature. Moreover, investigators do not know the delay between the application of the painful stimulus and the observation of the variation of the different neurovegetative variables. This constitutes a limit of the practitioners' confidence in these monitoring tools.

The nociception transmission pathways of to the vegetative centers and cortical areas are complex. Investigators hypothesis is that neurovegetative variations in response to nociceptive stimulation are not always associated with a cortical somatosensory response. In this project investigators investigate the relation between cortical (EEG) and vegetative reactions to acute and tonic nociceptive stimuli, as a preliminary step to apply these procedures to assess intraoperative reactions to nociceptive procedures in anesthetized patients.

Being tested
Nociceptive stimulation
Keywords
Nociceptive stimulation, Healthy volunteer, Simultaneous cortical activation, Neuro-vegetative response
Medical subject headings
Nociceptive Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Nociceptive stimulationOther

    These investigations in healthy volunteers will study the association between cerebral and neurovegetative (sympathetic and parasympathetic) electrophysiological responses in response to a controlled and tolerable pain stimulus, determined for each individual. The pain stimulus will be delivered using an electrically conductive glove used in clinical practice for transcutaneous therapeutic stimulation.

    The thresholds of nociception and tolerance will be determined in each healthy volunteer.

Study groups in NCT04925336
Study groupRoleWhat they receive
ExperimentalExperimentalNociceptive intervention arm
Receives: Other: Nociceptive stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Simultaneous scheme of cortical activation and neuro-vegetative responses to controlled nociceptive stimuli

    Simultaneous scheme of cortical activation and neuro-vegetative responses secondary to controlled nociceptive stimuli will be defined as the occurrence of at least one among the following:

    • Changes of time-frequency distribution of the electroencephalographic activity during phasic or tonic pain stimulation, compared to a prior baseline period.
    • Recording of cortical evoked responses during phasic pain stimulation in a time latency range between 100-500 msec.
    • Changes in parasympathetic tone measured by Analgesia/Nociception Index (ANI) method (threshold of 50/100) during phasic or tonic stimulation
    • Recording of the skin conductance reflex (skin sympathetic response) during phasic or tonic stimulations

    Measured: Day 1

Secondary outcomes (9)
  1. EEG time-frequency analysis during phasic pain stimulation

    Analysis of time-frequency maps to compare the amplitude in each frequency band during phasic stimulation condition and prior baseline period

    Measured: Day 1

  2. Latency of evoked responses to phasic stimulation

    Measure of mean latency of evoked responses to phasic stimulation in a time range of 100-500 msec

    Measured: Day 1

  3. Pick-to-pick amplitude of evoked responses to phasic stimulation

    Measure of mean pick-to-pick amplitude of evoked responses to phasic stimulation in a time range of 100-500 msec

    Measured: Day 1

  4. Quantification of skin sympathetic response during phasic stimulation

    Mean area under the curve of skin sympathetic response during phasic stimulation compared to the baseline periods before stimulation

    Measured: Day 1

  5. Qualitative Change of ANI Value during phasic stimulation

    Mean percentage of decrease of ANI value during phasic stimulation compared with the baseline period before stimulation

    Measured: Day 1

  6. EEG time-frequency analysis during tonic pain stimulation

    Analysis of time-frequency maps to compare the amplitude in each frequency band during tonic stimulation condition and prior baseline period

    Measured: Day 1

  7. Quantification of skin sympathetic response during tonic stimulation

    Mean area under the curve of skin sympathetic response during tonic stimulation compared to the baseline period before stimulation

    Measured: Day 1

  8. Qualitative Change of ANI Value during tonic stimulation

    Mean percentage of decrease of ANI value during tonic stimulation compared with the baseline period before stimulation

    Measured: Day 1

  9. Selection of dominant configuration of pattern in terms of sensitivity / specificity of the response to different types of nociceptive stimulation

    Among the EEG and neurovegetative modifications, investigators will select the dominant association according to the different types of nociceptive stimulation. The dominant association will constitute the pattern of interest. This pattern will be selected if present in more than 80% of subjects. If investigators obtain several patterns of interest associating different cortical or neurovegetative parameters, the final selected pattern will be made up of the smallest number of parameters in order to envisage its transfer in anesthesiological routine

    Measured: Day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jun 2021
  2. Study start6 Apr 2021
  3. Primary completion8 Jul 2021
  4. Study completion8 Jul 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
21 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04925336
Sponsor's protocol ID
69HCL19_0669
Acronym
ALGOBLOC-1
Status last verified
Oct 2021
First submitted
22 Jan 2020
Last updated
15 Oct 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Nociceptive stimulation in people with Nociceptive Pain and Anesthesia, run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Simultaneous scheme of cortical activation and neuro-vegetative responses to controlled nociceptive stimuli (time frame: Day 1). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Oct 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in